MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, ANEB has $9,421,997 in assets. $1,485,646 in debts. $9,041,570 in cash and cash equivalents.

Balance Sheets Overview

Debt to Asset Ratio
15.77%
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses
    • Loan commitment fees
    • Grant receivable
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Unit: Dollar
Balance Sheets
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
9,041,570 10,354,773 11,627,849
Grant receivable
56,783 9,825 73,218
Prepaid expenses
175,413 170,771 261,439
Total current assets
9,273,766 10,535,369 11,962,506
Loan commitment fees
148,231 165,670 183,110
Total assets
9,421,997 10,701,039 12,145,616
Accounts payable
554,862 607,539 224,175
Accrued expenses
930,784 356,282 263,513
Total liabilities
1,485,646 963,821 487,688
Common stock, 0.001 par value 75,000,000 shares authorized and 41,084,731 shares issued and outstanding at december 31, 2025 and june 30, 2025
41,086 41,086 41,086
Additional paid-in capital
85,941,523 85,742,993 85,505,349
Accumulated deficit
-78,046,258 -76,046,861 -73,888,507
Total stockholders equity
7,936,351 9,737,218 11,657,928
Total liabilities and stockholders equity
9,421,997 10,701,039 12,145,616
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses$175,413 Grant receivable$56,783 Cash and cashequivalents$9,041,570 Loan commitment fees$148,231 Total current assets$9,273,766 Total assets$9,421,997 Total liabilities andstockholders equity$9,421,997 Total stockholdersequity$7,936,351 Total liabilities$1,485,646 Accumulated deficit-$78,046,258 Additional paid-in capital$85,941,523 Accrued expenses$930,784 Accounts payable$554,862 Common stock, 0.001 parvalue 75,000,000...$41,086

Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals, Inc. (ANEB)